Hrt Financial LP Aravive, Inc. Transaction History

Hrt Financial LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$1.25 - $1.92 $158,827 - $243,959	127,062 New	127,062 $160,000
Q4 2021 Feb 14, 2022	SELL	$2.19 - $4.07 $58,580 - $108,868	-26,749 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$3.67 - $5.8 $11,332 - $17,910	-3,088 Reduced 10.35%	26,749 $99,000
Q2 2021 Aug 16, 2021	BUY	$4.65 - $6.42 $138,742 - $191,553	29,837 New	29,837 $178,000

28.1K

Ticker ARAV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,518,300
Description
Aravive, Inc., a clinical-stage biopharmaceutical company, develops treatments for life-threatening diseases, including cancer and fibrosis in the United States. Its lead product candidate is batiraxcept, an ultrahigh-affinity, decoy protein that targets the GAS6-AXL signaling pathway, which is in Phase III clinical trial for the treatment of pl...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.